Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/05/2012
PIL Nexium 20mg, 40mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 05/10/2011 and displayed until 21/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to drug interactions
Updated on 03/08/2011 and displayed until 05/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to side-effects
  • Change to dosage and administration
Updated on 07/07/2011 and displayed until 03/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
Updated on 04/11/2009 and displayed until 07/07/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to manufacturer contact details
Updated on 02/06/2009 and displayed until 04/11/2009
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to dosage and administration
  • Change due to user-testing of patient information
Updated on 21/07/2008 and displayed until 02/06/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 18/05/2007 and displayed until 21/07/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to drug interactions
  • Change to dosage and administration
Updated on 29/03/2007 and displayed until 18/05/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 01/11/2004 and displayed until 29/03/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 25/08/2004 and displayed until 01/11/2004
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to side-effects
Updated on 19/12/2003 and displayed until 25/08/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 12/03/2003 and displayed until 19/12/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/03/2003 and displayed until 12/03/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 15/10/2002 and displayed until 03/03/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 27/09/2001 and displayed until 15/10/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 04/10/2000 and displayed until 27/09/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  esomeprazole magnesium trihydrate